½ÃÀ庸°í¼­
»óǰÄÚµå
1578840

¼¼°èÀÇ Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå : ¿ëµµ, ¸âºê·¹ÀÎ À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ, ±â¼úº° ¿¹Ãø(2025-2030³â)

Polyethersulfone Medical Membrane Market by Application (Food and Beverage, Hemodialysis, Pharmaceutical Filtration), Membrane Type (Flat Sheet Membranes, Hollow Fiber Membranes), End User, Technology - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀåÀº 2023³â¿¡ 21¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 22¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 4.64%·Î ¼ºÀåÇÏ¿©, 2030³â¿¡´Â 29¾ï 7,000 ¸¸¹Ì ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Æú¸®¿¡Å׸£¼úÆù(PES) ÀǷḷÀº ¿­ ¾ÈÁ¤¼º, ±â°èÀû °­µµ ¹× ¿ì¼öÇÑ ³»È­ÇмºÀ¸·Î ÀÎÇØ ÀÇ·á¿ëÀ¸·Î ³Î¸® »ç¿ëµÇ´Â °í¼º´É Æú¸®¸ÓÀÔ´Ï´Ù. PES ¸âºê·¹ÀÎÀº ÁÖ·Î ¿©°ú °øÁ¤, Ç÷¾× Åõ¼®, ÀÇ·á±â±âÀÇ ºÎǰÀ¸·Î »ç¿ëµÇ¸ç °Ç°­ °ü¸® ºÐ¾ß¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. PES ¸âºê·¹ÀÎÀÇ Çʿ伺Àº È¿À²ÀûÀÌ°í ¾ÈÀüÇÑ È¯ÀÚ °á°ú¿¡ ÇʼöÀûÀÎ ³ôÀº Åõ°ú¼º°ú ¼±ÅüºÀ» Á¦°øÇÏ´Â ´É·ÂÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ÃÖÁ¾ ¿ëµµÀÇ ¹üÀ§´Â º´¿ø ¹× Ŭ¸®´Ð¿¡¼­ ¿¬±¸¼Ò ¹× ÀÇ·á±â±â Á¦Á¶¾÷ü¿¡ À̸£±â±îÁö ±¤´ëÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ´Â °ÍÀº ¸¸¼º ½ÅÀ庴ÀÇ À¯º´·ü Áõ°¡, ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºÀÇ Áøº¸, ÀǾàǰ¿¡ À־ÀÇ °íǰÁú ¿©°ú ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÃÖ±ÙÀÇ ÀáÀçÀû ±âȸ Áß Çϳª´Â ¼øµµ¿Í °­µµ°¡ °¡Àå Áß¿äÇÑ ¹ÙÀÌ¿À ÀǾàǰ ¿©°ú¿¡¼­ PES ¸âºê·¹ÀÎÀÇ Àû¿ëÀ» È®´ëÇÏ´Â °ÍÀ̸ç, °Ç°­ °ü¸® ÀÎÇÁ¶ó ÅõÀÚ Áõ°¡·Î ÀÎÇÑ ½ÅÈï ±¹°¡ÀÇ ÀáÀçÀû ¼ºÀåµµ ±× Áß ÇϳªÀÔ´Ï´Ù. ±×·¯³ª ½ÃÀåÀº ³ôÀº Á¦Á¶ ºñ¿ë°ú Æú¸® ºñ´Ò ¸®µ§ Ç÷ç¿À ¶óÀ̵å(PVDF) ¹× Æú¸®¿¡Å׸£¿¡Å׸£ÄÉÅæ(PEEK)°ú °°Àº ´Ù¸¥ ¸· Àç·á¿ÍÀÇ °æÀï°ú °°Àº Á¦¾à¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼¼°èÀÇ °Ç°­ ±âÁذú °ü·ÃµÈ ±ÔÁ¦ °úÁ¦µµ ¼ºÀåÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °úÁ¦¸¦ ±Øº¹Çϱâ À§ÇØ, ±â¼ú Çõ½Å°ú ¿¬±¸´Â ºñ¿ë È¿À²ÀûÀÎ Á¦Á¶ ±â¼ú°ú ¸· ¿©°ú È¿À²°ú »ýü ÀûÇÕ¼º Çâ»ó¿¡ ÃÊÁ¡À» ¸ÂÃâ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¦Á¶ °øÁ¤¿¡¼­ ȯ°æÀÇ Áö¼Ó°¡´É¼ºÀ» °­Á¶ÇÏ´Â °ÍÀº °æÀï ¿ìÀ§¸¦ °¡Á®¿Ã ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀ̸ç, ƯÈ÷ ´Ù¾çÇÑ ÀÇ·á¿ë¿¡ ´ëÀÀÇÒ ¼ö ÀÖ´Â ´Ù±â´É¸·À̳ª ÇÏÀ̺긮µå¸·ÀÇ °³¹ß¿¡ À־, Çõ½ÅÀÇ ¿©Áö°¡ Å®´Ï´Ù. ±â¾÷Àº ÀÇ·á±â°ü°úÀÇ Àü·«Àû Á¦ÈÞ¸¦ ¿ì¼±Çϰí R&D¿¡ ÅõÀÚÇÔÀ¸·Î½á ÁøÈ­ÇÏ´Â ±ÔÁ¦ »óȲ¿¡ ´ëÀÀÇϸ鼭 °æÀï ±¸µµ¸¦ ¼±Á¡ÇØ¾ß ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¿ªÇÐÀ» ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ±âÁ¸ÀÇ ±âȸ¸¦ Ȱ¿ëÇϰí Á¦¾àÀ» È¿°úÀûÀ¸·Î ±Øº¹ÇÒ ¼ö ÀÖ°Ô µÇ¾î °­·ÂÇÑ ½ÃÀå ¼ºÀåÀÌ ÃËÁøµË´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 21¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 22¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 29¾ï 7,000¸¸ ´Þ·¯
º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR)(%) 4.64%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ðÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º ½ÅÀ庴ÀÇ Åõ¼®, ¿©°ú ¿ëµµ¿¡ À־ÀÇ Æú¸®¿¡Å׸£¼úÆù ÀÇ·á¿ë ¸·ÀÇ Ã¤¿ë Áõ°¡
    • ¹ÙÀÌ¿ÀÀǾàǰ ¹× ÇコÄÉ¾î »ê¾÷¿¡ À־, ¼º´É°ú ¾ÈÀü¼ºÀÇ Çâ»óÀ» ¸ñÀûÀ¸·Î ÇÑ °íµµÀÇ·á¿ë¸·¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ºñ¿ë È¿À²ÀûÀ̰í È¿À²ÀûÀÎ ÀÇ·á¿ë ¸·À¸·Î À̾îÁö´Â ¸· Á¦Á¶ °øÁ¤ÀÇ ±â¼úÀû Áøº¸
    • Çõ½ÅÀûÀÎ ¸âºê·¹ÀÎ ¼Ö·ç¼ÇÀ» Áö¿øÇϱâ À§ÇÑ ÀÇ·á ÀÎÇÁ¶ó ¹× ÀÇ·á ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº Á¦Á¶ ºñ¿ë°ú ÷´Ü ±â¼ú·ÂÀÇ Çʿ伺Àº Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå¿¡ ´ëÇÑ »õ·Î¿î ÁøÀÔÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.
  • ½ÃÀå ±âȸ
    • ½ÅÈï °æÁ¦ ±¹°¡¿¡¼­ÀÇ ÀÇ·á ÀÎÇÁ¶ó Á¤ºñÀÇ ÁøÀü¿¡ ÀÇÇÑ Æú¸®¿¡Å׸£¼úÆù ÀÇ·á¿ë ¸·ÀÇ È®´ë °¡´É¼º
    • ¸¸¼º Áúȯ °ü¸®¿¡ À־ÀÇ Æú¸®¿¡Å׸£¼úÆù ÀǷḷÀÇ Çõ½ÅÀû ¿ëµµÀÇ °³¹ß
    • Àå±â ÀÌ½Ä ¼ö¼ú Áõ°¡¿¡ ¼ö¹ÝÇÏ´Â »ýü ÀûÇÕ¼º Æú¸®¿¡Å׸£¼úÆù¸· ¼ö¿ä Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ±ÔÁ¦»óÀÇ Çãµé°ú ¾ö°ÝÇÑ ÄÄÇöóÀ̾𽺠¿ä°Ç¿¡ ÀÇÇØ Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå ½ÃÀå È®´ë ³ë·ÂÀÌ Á¦ÇѵȴÙ

Porter's Five Forces : Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces Framework´Â Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå¿¡¼­ ¿ÜºÎ ¿µÇâÀ» ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À§ Æ÷Áö¼Å´Ï À̸¦ ÅëÇØ ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕÀÇ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» Çϱâ À§Çؼ­ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Æò°¡¸¦ ÅëÇØ ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ, ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º ½ÅÀ庴ÀÇ Åõ¼® ¹× ¿©°ú ¿ëµµ¿¡ À־ÀÇ Æú¸®¿¡Å׸£¼úÆù ÀÇ·á¿ë ¸·ÀÇ Ã¤¿ë Áõ°¡
      • ¹ÙÀÌ¿À ÀǾàǰ ¹× ÇコÄÉ¾î ¾÷°è¿¡¼­´Â ¼º´É°ú ¾ÈÀü¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ °í±Þ ÀǷḷ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
      • ¸· Á¦Á¶ °øÁ¤ÀÇ ±â¼úÀû Áøº¸¿¡ ÀÇÇØ ºñ¿ë È¿À²°ú È¿À²ÀÌ ¿ì¼öÇÑ ÀÇ·á¿ë ¸·ÀÌ ½ÇÇö
      • Çõ½ÅÀûÀÎ ¸âºê·¹ÀÎ ¼Ö·ç¼ÇÀ» Áö¿øÇϱâ À§ÇØ ÀÇ·á ÀÎÇÁ¶ó¿Í ÀÇ·á Á¶»ç¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚ°¡ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ³ôÀº »ý»ê ºñ¿ë°ú ³ôÀº ±â¼ú·ÂÀÇ Çʿ伺À¸·Î ½Å±Ô Âü°¡ÀÚ´Â Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå
    • ±âȸ
      • ÇコÄɾî ÀÎÇÁ¶ó Á¤ºñÀÇ ÁøÀü¿¡ ÀÇÇØ ½ÅÈï±¹¿¡ À־ÀÇ Æú¸®¿¡Å׸£ ¼úÆù ÀÇ·á¿ë¸·ÀÇ È®´ëÀÇ °¡´É¼º
      • ¸¸¼º Áúȯ °ü¸®¿¡ À־ÀÇ Æú¸®¿¡Å׸£¼úÆù ÀÇ·á¿ë ¸·ÀÇ Çõ½ÅÀûÀÎ ¿ëµµÀÇ °³¹ß
      • Àå±â ÀÌ½Ä ¼ö¼ú Áõ°¡¿¡ ÀÇÇØ »ýü ÀûÇÕ¼º Æú¸®¿¡Å׸£¼úÆù¸· ¼ö¿ä°¡ Áõ°¡
    • °úÁ¦
      • ±ÔÁ¦»óÀÇ Àå¾Ö¹°°ú ¾ö°ÝÇÑ ÄÄÇöóÀ̾𽺠¿ä±¸ »çÇ×Àº ½ÃÀå È®´ë ³ë·ÂÀ» Á¦ÇÑÇÕ´Ï´Ù. Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå : ¿ëµµº°

  • ½Äǰ ¹× À½·á
    • º´ÀÌ µé¾î°£ ½Ä¼ö
    • À¯Á¦Ç° °¡°ø
  • Ç÷¾×Åõ¼®
    • Åõ¼®ÀåÄ¡
    • Ç÷¾× ¿©°ú±â
  • ÀǾàǰ ¿©°ú
    • ¸ê±Õ ¿©°ú
    • ¹ÙÀÌ·¯½º ¿©°ú
  • ¹°ÀÇ Á¤È­
    • »ê¾÷
    • ÁÖÅÿë

Á¦7Àå Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå : ¸âºê·¹ÀÎ À¯Çüº°

  • Ç÷§ ½ÃÆ®¸·
  • Áß°ø»ç¸·
    • ³ª¼±Çü ¿îµå
    • °ü»ó

Á¦8Àå Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ½ÄÀ½·á ¾÷°è
  • º´¿ø
    • ÀÔ¿øÈ¯ÀÚ
    • ¿Ü·¡È¯ÀÚ
  • Á¦¾à, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷
  • ¿¬±¸½Ç

Á¦9Àå Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå : ±â¼úº°

  • Á¤¹Ð¿©°ú
  • ³ª³ë¿©°ú
  • Çѿܿ©°ú

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Æú¸®¿¡Å׸£¼úÆù ÀǷḷ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • 3M Company
  • Advantec MFS
  • Asahi Kasei Corporation
  • Cobetter Filtration
  • GE Healthcare
  • Koch Membrane Systems
  • Lenntech
  • Merck Millipore
  • Microdyn-Nadir GmbH
  • Microza
  • Pall Corporation
  • Parker Hannifin
  • Pentair
  • Restek Corporation
  • Sartorius AG
  • Sigma-Aldrich Corporation
  • Sterlitech Corporation
  • Synder Filtration
  • Thermo Fisher Scientific
  • Toray Industries
BJH 24.11.05

The Polyethersulfone Medical Membrane Market was valued at USD 2.16 billion in 2023, expected to reach USD 2.25 billion in 2024, and is projected to grow at a CAGR of 4.64%, to USD 2.97 billion by 2030.

Polyethersulfone (PES) medical membranes are high-performance polymers widely used in medical applications for their thermal stability, mechanical strength, and excellent chemical resistance. They are primarily employed in filtration processes, hemodialysis, and as a component in medical devices, emphasizing their crucial role in the healthcare sector. The necessity of PES membranes arises from their ability to provide high permeability and selectivity, which is vital for efficient and safe patient outcomes. The end-use scope is vast, ranging from hospitals and clinics to research laboratories and medical device manufacturers. The market is driven by the increasing prevalence of chronic kidney diseases, advancements in bioprocessing, and a rising demand for high-quality filtration in pharmaceuticals. One of the latest potential opportunities lies in expanding the application of PES membranes in biopharmaceutical filtration, where purity and strength are paramount, alongside potential growth in emerging countries due to increased healthcare infrastructure investments. However, the market faces limitations such as high production costs and competition from other membrane materials like polyvinylidene fluoride (PVDF) and polyetheretherketone (PEEK). Regulatory challenges related to global health standards can also constrain growth. To overcome these challenges, innovation and research could focus on cost-effective manufacturing techniques and enhancing the membrane's filtration efficiency and biocompatibility. Emphasizing environmental sustainability in production processes can also offer a competitive advantage. The market is dynamic, with substantial room for innovation, particularly in developing multi-functional and hybrid membranes that can address diverse medical applications. Businesses should prioritize strategic collaborations with medical institutions and invest in R&D to stay ahead of the competition while aligning with evolving regulatory landscapes. Understanding these dynamics will enable firms to capitalize on existing opportunities and navigate constraints effectively, thus fostering robust market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.16 billion
Estimated Year [2024] USD 2.25 billion
Forecast Year [2030] USD 2.97 billion
CAGR (%) 4.64%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Polyethersulfone Medical Membrane Market

The Polyethersulfone Medical Membrane Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing adoption of polyethersulfone medical membranes in dialysis and filtration applications for chronic kidney diseases
    • Growing demand for advanced medical membranes in biopharmaceutical and healthcare industries for enhanced performance and safety
    • Technological advancements in membrane manufacturing processes leading to cost-effective and efficient medical membranes
    • Rising government investments in healthcare infrastructure and medical research to support innovative membrane solutions
  • Market Restraints
    • High production costs and need for advanced technological capabilities restrict new entrants in the Polyethersulfone Medical Membrane Market
  • Market Opportunities
    • Expansion potential in emerging economies for polyethersulfone medical membranes due to increasing healthcare infrastructure development
    • Developing innovative applications for polyethersulfone medical membranes in chronic disease management
    • Growth in demand for biocompatible polyethersulfone membranes driven by rising organ transplant surgeries
  • Market Challenges
    • Regulatory hurdles and stringent compliance requirements limit market expansion efforts for Polyethersulfone Medical Membrane Market

Porter's Five Forces: A Strategic Tool for Navigating the Polyethersulfone Medical Membrane Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Polyethersulfone Medical Membrane Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Polyethersulfone Medical Membrane Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Polyethersulfone Medical Membrane Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Polyethersulfone Medical Membrane Market

A detailed market share analysis in the Polyethersulfone Medical Membrane Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Polyethersulfone Medical Membrane Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Polyethersulfone Medical Membrane Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Polyethersulfone Medical Membrane Market

A strategic analysis of the Polyethersulfone Medical Membrane Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Polyethersulfone Medical Membrane Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Advantec MFS, Asahi Kasei Corporation, Cobetter Filtration, GE Healthcare, Koch Membrane Systems, Lenntech, Merck Millipore, Microdyn-Nadir GmbH, Microza, Pall Corporation, Parker Hannifin, Pentair, Restek Corporation, Sartorius AG, Sigma-Aldrich Corporation, Sterlitech Corporation, Synder Filtration, Thermo Fisher Scientific, and Toray Industries.

Market Segmentation & Coverage

This research report categorizes the Polyethersulfone Medical Membrane Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Food and Beverage, Hemodialysis, Pharmaceutical Filtration, and Water Purification. The Food and Beverage is further studied across Bottled Water and Dairy Processing. The Hemodialysis is further studied across Dialyzers and Hemofilters. The Pharmaceutical Filtration is further studied across Sterile Filtration and Virus Filtration. The Water Purification is further studied across Industrial and Residential.
  • Based on Membrane Type, market is studied across Flat Sheet Membranes and Hollow Fiber Membranes. The Hollow Fiber Membranes is further studied across Spiral Wound and Tubular.
  • Based on End User, market is studied across Food & Beverage Industry, Hospitals, Pharmaceutical & Biotechnology Companies, and Research Laboratories. The Hospitals is further studied across Inpatient and Outpatient.
  • Based on Technology, market is studied across Microfiltration, Nanofiltration, and Ultrafiltration.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of polyethersulfone medical membranes in dialysis and filtration applications for chronic kidney diseases
      • 5.1.1.2. Growing demand for advanced medical membranes in biopharmaceutical and healthcare industries for enhanced performance and safety
      • 5.1.1.3. Technological advancements in membrane manufacturing processes leading to cost-effective and efficient medical membranes
      • 5.1.1.4. Rising government investments in healthcare infrastructure and medical research to support innovative membrane solutions
    • 5.1.2. Restraints
      • 5.1.2.1. High production costs and need for advanced technological capabilities restrict new entrants in the Polyethersulfone Medical Membrane Market
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion potential in emerging economies for polyethersulfone medical membranes due to increasing healthcare infrastructure development
      • 5.1.3.2. Developing innovative applications for polyethersulfone medical membranes in chronic disease management
      • 5.1.3.3. Growth in demand for biocompatible polyethersulfone membranes driven by rising organ transplant surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and stringent compliance requirements limit market expansion efforts for Polyethersulfone Medical Membrane Market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Polyethersulfone Medical Membrane Market, by Application

  • 6.1. Introduction
  • 6.2. Food and Beverage
    • 6.2.1. Bottled Water
    • 6.2.2. Dairy Processing
  • 6.3. Hemodialysis
    • 6.3.1. Dialyzers
    • 6.3.2. Hemofilters
  • 6.4. Pharmaceutical Filtration
    • 6.4.1. Sterile Filtration
    • 6.4.2. Virus Filtration
  • 6.5. Water Purification
    • 6.5.1. Industrial
    • 6.5.2. Residential

7. Polyethersulfone Medical Membrane Market, by Membrane Type

  • 7.1. Introduction
  • 7.2. Flat Sheet Membranes
  • 7.3. Hollow Fiber Membranes
    • 7.3.1. Spiral Wound
    • 7.3.2. Tubular

8. Polyethersulfone Medical Membrane Market, by End User

  • 8.1. Introduction
  • 8.2. Food & Beverage Industry
  • 8.3. Hospitals
    • 8.3.1. Inpatient
    • 8.3.2. Outpatient
  • 8.4. Pharmaceutical & Biotechnology Companies
  • 8.5. Research Laboratories

9. Polyethersulfone Medical Membrane Market, by Technology

  • 9.1. Introduction
  • 9.2. Microfiltration
  • 9.3. Nanofiltration
  • 9.4. Ultrafiltration

10. Americas Polyethersulfone Medical Membrane Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Polyethersulfone Medical Membrane Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Polyethersulfone Medical Membrane Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Advantec MFS
  • 3. Asahi Kasei Corporation
  • 4. Cobetter Filtration
  • 5. GE Healthcare
  • 6. Koch Membrane Systems
  • 7. Lenntech
  • 8. Merck Millipore
  • 9. Microdyn-Nadir GmbH
  • 10. Microza
  • 11. Pall Corporation
  • 12. Parker Hannifin
  • 13. Pentair
  • 14. Restek Corporation
  • 15. Sartorius AG
  • 16. Sigma-Aldrich Corporation
  • 17. Sterlitech Corporation
  • 18. Synder Filtration
  • 19. Thermo Fisher Scientific
  • 20. Toray Industries
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦